Class II
Ongoing
Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300,…
Why: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
- Company
- Cipla USA, Inc.
Warren, NJ, United States - Reported
- Apr 22, 2026
- Recall started
- Mar 16, 2026
- Where sold
- Nationwide in the USA
- Amount
- 63,192 bottles
- Full product description
- Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02
- Lots / codes affected
- Lot, expiry: 4PB0224, exp March-2026; 4PB0505, 4PB0506, 4PB0507, exp September-2026; 5PB0564, exp April-2027
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.